key: cord-0051876-0u7e7513
authors: Tummalapalli, Sri Lekha; Ibrahim, Said A.
title: Alternative Payment Models and Opportunities to Address Disparities in Kidney Disease
date: 2020-10-21
journal: Am J Kidney Dis
DOI: 10.1053/j.ajkd.2020.09.008
sha: 16db8a484a0749c4bf56311169cc14c01b565a4e
doc_id: 51876
cord_uid: 0u7e7513

nan

Health and health care disparities are pervasive across the spectrum of kidney disease. 1 Kidney failure disproportionately affects Black and Hispanic persons, those with low socioeconomic status, and homeless and housing insecure individuals. [2] [3] [4] [5] The etiology of these disparities stems from complex interrelationships between social disadvantage, medical comorbidities, genetic factors, and historical/structural racism. In the context of the disproportionate impact of coronavirus disease 2019 (COVID- 19) on Black and Hispanic communities, 6 its bidirectional association with kidney disease, 7, 8 Order. Notably, however, a discussion surrounding kidney health disparities has been largely absent in federal communications surrounding AAKH. While other policy-level interventions such as Medicaid Expansion may be effective in reducing disparities, the current role of APMs to address disparities remains limited. 10 Moving forward, it is imperative that new payment models and care delivery strategies be thoughtfully and intentionally designed to address disparities in kidney care.

This editorial outlines current knowledge and proposed solutions such that APMs can mitigate rather than potentiate disparities in kidney care.

APMs are reimbursement mechanisms that reward clinicians and health systems for high-quality, cost-efficient care. APMs often incorporate financial incentives and penalties, and J o u r n a l P r e -p r o o f have shown to reduce costs across a variety of settings. 11, 12 Nephrology has long been an early adopter of APMs, including the ESRD Prospective Payment System (PPS), ESRD Quality Incentive Program (QIP), and ESCOs, which involve differing levels of financial risk sharing, moving away from solely fee-for-service driven care (Figure 1) 13 Thus far, the impact of APMs on kidney care disparities has been understudied. One analysis found that differences in erythropoietin doses or laboratory values between Black and non-Black patients did not widen or narrow between August 2010 and December 2011, after bundled payments in the ESRD PPS were implemented. 14 Independent dialysis facilities serving fewer patients with employerbased insurance had a higher prevalence of hemoglobin levels <10 g/dL under the ESRD PPS, compared with independent facilities with more commercially insured patients, providing evidence that bundled payments may have contributed to socioeconomic disparities in anemia management. 15 In the ESRD QIP, dialysis facilities serving higher proportions of patients with dualeligibility status, Black race, and lower neighborhood-level income had lower quality scores and were more likely to be penalized. 16, 17 While lower QIP scores are associated with higher mortality, 18 the impact of the QIP program itself on disparities in care or health outcomes for patients on dialysis is unclear. Regarding ESCOs, these ACOs were associated with fewer hospitalizations and less catheter usage, 19 and ESCO-aligned patients were more likely to be J o u r n a l P r e -p r o o f Black. 20 Black participants in ESCOs had significant reductions in costs and increases in fistula usage compared with those in matched comparison facilities, whereas white participants did not have significant changes in costs or fistula usage. 21 Taken together, the findings of these initial studies are mixed, and do not yet suggest an overall conclusion of the impact of APMs on kidney care disparities.

The new Kidney Care Choices Model incentivizes performance on quality measures related to patient activation, depression remission, hypertension control, and vascular access. 22 Other measures are under development, including a standardized mortality ratio and a measure of delayed progression to kidney failure. As a first step to better understand disparities in care delivery, quality measures in Kidney Care Choices and other APMs should be stratified by race/ethnicity and socioeconomic status, as recommended by the National Quality Forum. 23

Using these "disparities-sensitive measures" can allow health systems and CMS to monitor relative and absolute health disparities over time, more appropriately target care management resources, and ensure that care delivery interventions do not exacerbate disparities. Kidney Care Choices and other APMs could test strategies for rewarding improvement on quality measures, including closing disparities.

APMs measure the quality and cost of care using risk adjustment to account for differences in patient populations. Risk adjustment for CMS programs traditionally uses Hierarchical Condition Categories which account for patient comorbidities but do not incorporate social risk factors, which are defined as adverse social conditions associated with poor health, such as low socioeconomic position, being in a disadvantaged racial/ethnic group, lack of social relationships, and adverse residential and community context. 24 Social risk factors are highly prevalent among patients with kidney disease and are associated with adverse outcomes. 1 Not accounting for social risk factors results in higher penalties to nephrology practices and dialysis J o u r n a l P r e -p r o o f facilities that serve disadvantaged populations, who typically score less well on quality measures. Thus, designing socially-informed payment models is critical to ensure that APMs do not have unintended consequences of exacerbating disparities in kidney disease.

However, there is also concern that adjusting for social risk factors would mask and 

In order for social factors to be incorporated in kidney APMs, payment models could rely on the limited social determinants found in claims data, or collect more granular individual-level social determinants, which are currently not being systematically captured. Social determinants-the environmental determinants or conditions into which people are born, grow, live, work and age-have a substantial impact on health-related outcomes. A myriad of social determinants are associated with limited health care access, low health status, and poor health outcomes. 26 Kidney disease quality of care is highly influenced by social determinants and social needs. There are now structured tools to screen for social needs, including the Accountable Health Communities (AHC) Health-Related Social Needs (HRSN) Screening Tool, recently developed by CMS in conjunction with the National Academy of Medicine. 27 The AHC HRSN is J o u r n a l P r e -p r o o f a 10-item self-administered tool assessing 5 core domains (housing instability, food insecurity, transportation problems, utility help needs, and interpersonal safety), in addition to 8 supplemental domains.

We propose that universal social needs screening be implemented and studied in dialysis facilities with the AHC HRSN or other tools. 28 Dialysis facilities may be highly feasible sites to collect individual-level social needs using existing staff and resources, given the high frequency of patient visits and embedded multidisciplinary care teams. Much of this data is already collected by social workers in dialysis facilities, but the use of a structured assessment tool has two key advantages. First, a systematic approach would ensure that unmet social needs are universally collected and intervened upon as part of medical care. For example, connecting housing insecure individuals to community resources for permanent housing may facilitate greater home dialysis uptake, in line with AAKH goals. Second, screening tools would capture this information in structured data formats, facilitating research and information sharing in the electronic health record. Ultimately, existing CROWNWeb infrastructure could be used to report social factors to CMS for potential performance and payment adjustment. Future research would estimate the additional staff time and costs associated with social needs collection and reporting, and the optimal frequency of collection, which could start with yearly.

In summary, amidst longstanding disparities in kidney care, APMs carry the potential to mitigate these disparities and should be immediately leveraged for this purpose. Disparitiessensitive quality measures, social risk factor adjustment, and universal social needs screening are potential solutions that should be further evaluated in new voluntary and mandatory payment models in AAKH. It is critical that APMs and other policies and care delivery interventions work to promote health equity, 23 shifting towards third-and fourth-generation disparities research that provides solutions to eliminate disparities. 29

J o u r n a l P r e -p r o o f 

Disparities in the burden, outcomes, and care of chronic kidney disease

US Renal Data System 2019 Annual Data Report: epidemiology of kidney disease in the United States

Socioeconomic factors and racial disparities in kidney disease outcomes

Homelessness and risk of end-stage renal disease

Dialysis for Patients With End-stage Renal Disease Who Are Homeless

Racial and Ethnic Disparities in Population Level Covid-19 Mortality

Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease

Acute kidney injury in patients hospitalized with COVID-19

CMS Innovation Center Models COVID-19 Related Adjustments

Achieving equity in dialysis care and outcomes: The role of policies

The Medicare Access and CHIP Reauthorization Act: Implications for Nephrology

Cost of joint replacement using bundled payment models

Do Medicare Accountable Care Organizations Reduce Disparities After Spinal Fracture?

Has dialysis payment reform led to initial racial disparities in anemia and mineral metabolism management?

Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System

The Role Of Social Risk Factors In Dialysis Facility Ratings And Penalties Under A Medicare Quality Incentive Program

Early winners and losers in dialysis center pay-forperformance

Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States

Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease

Characteristics of Markets and Patients Served by ESRD Seamless Care Organizations

Comprehensive End-Stage Renal Disease Care (CEC) Model. Performance Year 1 Annual Evaluation Report

Center for Medicare and Medicaid Innovation (CMMI). Centers for Medicare & Medicaid Services (CMS). Kidney Care Choices (KCC) Model: Request for Applications (RFA)

National Academies of Sciences, Engineering, and Medicine. Accounting for Social Risk Factors in Medicare Payment: Identifying Social Risk Factors

Socioeconomic Factors and Racial and Ethnic Differences in the Initiation of Home Dialysis

Commission on Social Determinants of H. Closing the gap in a generation: health equity through action on the social determinants of health

National Association of Community Health Centers. PRAPARE: Protocol for Responding to and Assessing Patients' Assets, Risks, and Experiences Implementation and Action Toolkit

Toward a fourth generation of disparities research to achieve health equity

Integrating Medicaid supplemental payments into value-based purchasing. The Commonwealth Fund